User experience of home-based AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay test
Abstract The urgent need to scale up testing capacity during the COVID-19 pandemic has prompted the rapid development of point-of-care diagnostic tools such as lateral flow immunoassays (LFIA) for large-scale community-based rapid testing. However, studies of how the general public perform when usin...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-05097-y |